Previously, Ozempic and most other GLP-1s (shorthand for glucagon-like peptide-1 receptor agonists) had only been approved to treat Type 2 diabetes
While mild muscle discomfort during weight loss may not require immediate medical attention, certain features warrant prompt clinical evaluation to exclude serious underlying conditions
The insulin-like growth factor I system : physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome
GLP-1 medications can help lower inflammation and support weight loss, both of which are important in PsA
Wang D, Fang J, Wen S, Li Q, Wang J, Yang L, et al
No effects on body weight or glycemic control were reported in this study